One of the more notable successes of President Donald Trump’s first term was how the administration was able to develop ...

August 14, 2025Traws Pharma, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-8.75. Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Traws Pharma, ...

One of the more notable successes of President Donald Trump’s first term was how the administration was able to develop ...

Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...

On Aug. 5, Robert F. Kennedy Jr. posted video to X announcing HHS was canceling mRNA vaccine research, confusing the Trump ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...

Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

What makes this doubly frustrating is that Kennedy and his back-to-the-past approach to public health would be better off ...